Abstract
Stenotrophomonas maltophilia can cause various clinical diseases; however, pleural infections due to S. maltophilia are rare. We evaluated the clinical characteristics and outcomes of patients with pleural infections (complicated parapneumonic effusion or empyema) due to S. maltophilia who were treated at a medical center in Taiwan from 2004 to 2012. During the study period, 40 patients were treated for pleural infections due to S. maltophilia. The incidence of S. maltophilia pleural infections ranged from 2.66 per 1,000,000 patient-days in 2009 to 12.44 per 1,000,000 patient-days in 2011. Most of the patients with S. maltophilia pleural infections were immunocompromised male adults and all of the infections were acquired in healthcare settings. The majority of patients had polymicrobial pleural infections (n = 31, 77.5 %) and the most common pathogen was Pseudomonas aeruginosa (n = 12). The causes of pleural infections due to S. maltophilia were pneumonia due to S. maltophilia in two patients (5 %), post-surgical/tube thoracostomy in 26 (65 %) patients, and fistula (bronchopleural, esophagopleural and biliopleural) in 12 (30 %) patients. The 14-day and 30-day mortality rates were 32.5 % and 42.5 %, respectively. Pleural infections due to S. maltophilia are most commonly the result of surgical procedures, thoracostomy, and underlying fistulas. These infections are associated with a high mortality rate, especially among immunocompromised patients.
Similar content being viewed by others
References
Carmody LA, Spilker T, LiPuma JJ (2011) Reassessment of Stenotrophomonas maltophilia phenotype. J Clin Microbiol 49:1101–1103
Looney WJ, Narita M, Muhlemann K (2009) Stenotrophomonas maltophilia: an emerging opportunist human pathogen. Lancet Infect Dis 9:312–323
Brooke JS (2012) Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Microbiol Rev 25:2–41
Chang YT, Lin CY, Lu PL, Lai CC, Chen TC, Chen CY, Wu DC, Wang TP, Lin CM, Lin WR, Chen YH (2013) Stenotrophomonas maltophilia bloodstream infection: Comparison between community-onset and hospital-acquired infections. J Microbiol Immunol Infect S1684–1182(12)00175-2
Wu H, Wang JT, Shiau YR, Wang HY, Lauderdale TL, Chang SC, Hospitals TSAR (2012) A multicenter surveillance of antimicrobial resistance on Stenotrophomonas maltophilia in Taiwan. J Microbiol Immunol Infect 45:120–126
Fujita J, Yamadori I, Xu G, Hojo S, Negayama K, Miyawaki H, Yamaji Y, Takahara J (1996) Clinical features of Stenotrophomonas maltophilia pneumonia in immunocompromised patients. Respir Med 90:35–38
Nseir S, Di Pompeo C, Cavestri B, Jozefowicz E, Nyunga M, Soubrier S, Roussel-Delvallez M, Saulnier F, Mathieu D, Durocher A (2006) Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome. Crit Care Med 34:2959–2966
Safdar A, Rolston KV (2007) Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer. Clin Infect Dis 45:1602–1609
Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644–1655
Lee MR, Chen CM, Chuang TY, Huang YT, Hsueh PR (2013) Capsular serotypes and antimicrobial susceptibilities of Streptococcus pneumoniae causing invasive pneumococcal disease from 2009–2012 with an emphasis on serotype 19A in bacteraemic pneumonia and empyema and beta-lactam resistance. Int J Antimicrob Agents 42:395–402
Lee MR, Huang YT, Liao CH, Chuang TY, Wang WJ, Lee SW, Lee LN, Hsueh PR (2012) Clinical and microbiological characteristics of bacteremia caused by Eggerthella, Paraeggerthella, and Eubacterium species at a university hospital in Taiwan from 2001 to 2010. J Clin Microbiol 50:2053–2055
Lisboa T, Waterer GW, Lee YC (2011) Pleural infection: changing bacteriology and its implications. Respirology 16:598–603
Maskell NA, Davies CW, Nunn AJ, Hedley EL, Gleeson FV, Miller R, Gabe R, Rees GL, Peto TE, Woodhead MA, Lane DJ, Darbyshire JH, Davies RJ, First Multicenter Intrapleural Sepsis Trial (MIST1) Group (2005) U.K. (2005) Controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med 352:865–874
Tu CY, Hsu WH, Hsia TC, Chen HJ, Chiu KL, Hang LW, Shih CM (2006) The changing pathogens of complicated parapneumonic effusions or empyemas in a medical intensive care unit. Intensive Care Med 32:570–576
Mukhopadhyay C, Bhargava A, Ayyagari A (2003) Novel healthcare-associated infections by Stenotrophomonas maltophilia: first reported case from Lucknow, North India. J Clin Microbiol 41:3989–3990
Bini A, Grazia M, Petrella F, Stella F, Bazzocchi R (2004) Spontaneous biliopneumothorax (thoracobilia) following gastropleural fistula due to stomach perforation by nasogastric tube. Ann Thorac Surg 78:339–341
Liu Z, Zhao Z, Xiong J (1999) Analysis of clinical characteristics and drug sensitivity tests of lower respiratory tract infection by Xanthomonas maltophilia. Zhonghua Jie He He Hu Xi Za Zhi 22:211–213
Falagas ME, Kastoris AC, Vouloumanou EK, Rafailidis PI, Kapaskelis AM, Dimopoulos G (2009) Attributable mortality of Stenotrophomonas maltophilia infections: a systematic review of the literature. Future Microbiol 4:1103–1109
Rousseau A, Morcos M, Amrouche L, Foïs E, Casetta A, Rio B, Le Tourneaua A, Molina T, Rabbat A, Marie JP, Audouin J (2004) Lethal pulmonary hemorrhage caused by a fulminant Stenotrophomonas maltophilia respiratory infection in an acute myeloid leukemia patient. Leuk Lymphoma 45:1293–1296
Araoka H, Fujii T, Izutsu K, Kimura M, Nishida A, Ishiwata K, Nakano N, Tsuji M, Yamamoto H, Asano-Mori Y, Uchida N, Wake A, Taniguchi S, Yoneyama A (2012) Rapidly progressive fatal hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in hematologic malignancy. Transpl Infect Dis 14:355–363
Jamrozy-Witkowska AM, Grzybowski A, Grabska-Liberek I, Pawlik-Sobecka LA, Krzyzanowska-Berkowska PP (2010) Co-existence of Staphylococcus spp and Stenotrophomonas maltophilia infection in persistent endophthalmitis after cataract surgery. Clin Exp Optom 293:473–475
Horster S, Bader L, Seybold U, Eschler I, Riedel KG, Bogner JR (2009) Stenotrophomonas maltophilia induced post-cataract-surgery endophthalmitis: Outbreak investigation and clinical courses of 26 patients. Infection 37:117–122
Sood S, Vaid VK, Bhartiya H (2013) Meningitis due to Stenotrophomonas maltophilia after a Neurosurgical Procedure. J Clin Diagn Res 7:1696–1697
Araoka H, Fujii T, Izutsu K, Kimura M, Nishida A, Ishiwata K, Nakano N, Tsuji M, Yamamoto H, Asano-Mori Y, Uchida N, Wake A, Taniguchi S, Yoneyama A (2005) Life-threatening chronic enteritis due to colonization of the small bowel with Stenotrophomonas maltophilia. Gastroenterology 129:706–712
Denton M, Kerr KG (1998) Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev 11:57–80
Papadakis KA, Vartivarian SE, Vassilaki ME, Anaissie EJ (1995) Stenotrophomonas maltophilia: an unusual cause of biliary sepsis. Clin Infect Dis 21:1032–1034
Stanojevic S, Ratjen F, Stephens D, Lu A, Yau Y, Tullis E, Waters V (2013) Factors influencing the acquisition of Stenotrophomonas maltophilia infection in cystic fibrosis patients. J Cyst Fibros 12(6):575–583
Fihman V, Le Monnier A, Corvec S, Jaurequy F, Tankovic J, Jacquier H (2012) Stenotrophomonas maltophilia–the most worrisome threat among unusual non-fermentative gram-negative bacilli from hospitalized patients: a prospective multicenter study. J Infect 64:391–398
Rattanaumpawan P, Ussavasodhi P, Kiratisin P, Aswapokee N (2013) Epidemiology of bacteremia caused by uncommon non-fermentative gram-negative bacteria. BMC Infect Dis 13:167
Wang WS, Liu CP, Lee CM, Huang FY (2004) Stenotrophomonas maltophilia bacteremia in adults: four years’ experience in a medical center in northern Taiwan. J Microbiol Immunol Infect 37:359–365
LiPuma JJ (2003) Burkholderia and emerging pathogens in cystic fibrosis. Semin Respir Crit Care Med 24:681–692
LiPuma JJ (2000) Expanding microbiology of pulmonary infection in cystic fibrosis. Pediatr Infect Dis J 19:473–474
Tan R, Liu J, Li M, Huang J, Sun J, Qu H (2013) Epidemiology and antimicrobial resistance among commonly encountered bacteria associated with infections and colonization in intensive care units in a university-affiliated hospital in Shanghai. J Microbiol Immunol Infect S1684–1182(12)00241-1
Armand-Lefèvre L, Angebault C, Barbier F, Hamelet E, Defrance G, Ruppé E, Bronchard R, Lepeule R, Lucet JC, El Mniai A, Wolff M, Montravers P, Plésiat P, Andremont A (2013) Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients. Antimicrob Agents Chemother 57:1488–1495
Pathmanathan A, Waterer GW (2005) Significance of positive Stenotrophomonas maltophilia culture in acute respiratory tract infection. Eur Respir J 25:911–914
Aisenberg G, Rolston KV, Dickey BF, Kontoyiannis DP, Raad II, Safdar A (2007) Stenotrophomonas maltophilia pneumonia in cancer patients without traditional risk factors for infection, 1997–2004. Eur J Clin Microbiol Infect Dis 26:13–20
Falagas ME, Valkimadi PE, Huang YT, Matthaiou DK, Hsueh PR (2008) Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systemic review. J Antimicrob Chemother 62:889–894
Conflict of interest
There is no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lee, MR., Wang, HC., Yang, CY. et al. Clinical characteristics and outcomes of patients with pleural infections due to Stenotrophomonas maltophilia at a medical center in Taiwan, 2004–2012. Eur J Clin Microbiol Infect Dis 33, 1143–1148 (2014). https://doi.org/10.1007/s10096-014-2060-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-014-2060-8